HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamotsu Seki Selected Research

Glaucoma

1/2011Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamotsu Seki Research Topics

Disease

3Dry Eye Syndromes (Dry Eye Syndrome)
07/2019 - 01/2016
3Ganglion Cysts (Ganglion)
10/2013 - 07/2006
2Ischemia
06/2016 - 01/2011
2Optic Nerve Injuries
01/2012 - 11/2008
1Eye Injuries (Eye Injury)
09/2016
1Brain Injuries (Brain Injury)
06/2016
1Stroke (Strokes)
06/2016
1Hypoxia (Hypoxemia)
01/2012
1Glaucoma
01/2011
1Diplopia (Double Vision)
12/2002

Drug/Important Bio-Agent (IBA)

9Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
07/2019 - 07/2006
2Retinaldehyde (Retinal)IBA
01/2012 - 01/2011
1retinol palmitate (retinyl palmitate)FDA Link
01/2017
1Ophthalmic Solutions (Eye Drops)IBA
01/2017
1Bromodeoxyuridine (BrdU)IBA
06/2016
1N-Methylaspartate (NMDA)IBA
10/2013

Therapy/Procedure

1Intravitreal Injections
10/2013
1Conservative Treatment
12/2002